| Primary |
| Hypertension |
50.0% |
| Neuroendocrine Tumour |
50.0% |
|
| Hypertension |
50.0% |
| White Blood Cell Count Decreased |
50.0% |
|
| Secondary |
| Hypertension |
44.4% |
| Drug Use For Unknown Indication |
27.8% |
| Oedema Peripheral |
11.1% |
| Arthritis |
5.6% |
| Diabetes Mellitus |
5.6% |
| Multiple Allergies |
5.6% |
|
| Blood Pressure Increased |
33.3% |
| Pain |
33.3% |
| Product Quality Issue |
33.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.8% |
| Product Used For Unknown Indication |
24.0% |
| Hypertension |
11.7% |
| Chronic Obstructive Pulmonary Disease |
5.4% |
| Blood Pressure |
4.1% |
| Pain |
3.6% |
| Colorectal Cancer |
3.2% |
| Blood Cholesterol Increased |
3.0% |
| Osteoporosis |
2.3% |
| Depression |
2.0% |
| Premedication |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Insomnia |
1.7% |
| Smoking Cessation Therapy |
1.7% |
| Asthma |
1.6% |
| Nuclear Magnetic Resonance Imaging |
1.6% |
| Diabetes Mellitus |
1.5% |
| Nausea |
1.5% |
| Constipation |
1.3% |
| Vitamin Supplementation |
1.3% |
|
| Death |
6.7% |
| Hypovolaemia |
6.7% |
| Tooth Extraction |
6.7% |
| Urinary Tract Infection |
6.7% |
| Weight Decreased |
6.7% |
| Nausea |
5.6% |
| Pneumonia |
5.6% |
| Unevaluable Event |
5.6% |
| Abnormal Dreams |
4.5% |
| Dyspnoea |
4.5% |
| Fatigue |
4.5% |
| Insomnia |
4.5% |
| Lichenoid Keratosis |
4.5% |
| Sleep Apnoea Syndrome |
4.5% |
| Visual Impairment |
4.5% |
| Wegener's Granulomatosis |
4.5% |
| Nervousness |
3.4% |
| Pain |
3.4% |
| Paraesthesia |
3.4% |
| Swelling Face |
3.4% |
|
